title: Urinary stones in HIV-1-positive patients treated with indinavir.
authors.forename: M
authors.initials: M
authors.lastname: Daudon
authors.forename: L
authors.initials: L
authors.lastname: Estépa
authors.forename: J P
authors.initials: JP
authors.lastname: Viard
authors.forename: D
authors.initials: D
authors.lastname: Joly
authors.forename: P
authors.initials: P
authors.lastname: Jungers
mesh_terms: D000328:Adult; D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D005260:Female; D017320:HIV Protease Inhibitors / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D006679:HIV Seropositivity / Q000188:drug therapy*; D015497:HIV-1; D006801:Humans; D019469:Indinavir / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D014545:Urinary Calculi / Q000139:chemically induced* / Q000737:chemistry / Q000473:pathology
chemical_list: D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D019469:Indinavir